Our work is currently funded through the following sources:

• Starting in May 2021:

• • Open call on personalized breast cancer treatments from the Rosa sløfe (Pink Ribbon) campaign, Norwegian Cancer Society, for the project “Cis-regulatory signatures for improved identification and stratification of breast cancer subtypes”: NOK 4.999 millions over 4 years

---

• Since August 2019:
  • Young Research Talents grant from the Research Council of Norway for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: NOK 7.352 millions over 3 years
    

    ---

    

  • Open Call grant from the Norwegian Cancer Society for the project “Characterisation of cis-regulatory variations that dysregulate driver microRNAs in cancer”: 1.968 millions over 4 years

---

• Since May 2016:
  • Research Council of Norway (project #187615), Helse-Sør Øst, and the University of Oslo through the Centre for Molecular Medicine Norway (NCMM): NOK 18M over 5 years as start-up package to launch the Computational Biology & Gene Regulation Group.